![[current-page:title] logo](/sites/default/files/styles/logo/public/default_images/_no-logo.png?itok=8OH0tuUw){kind=logo}
Address
Nextech Invest Ltd
35 Scheuchzerstrasse
8006 Zurich
Switzerland
Phone
Website
Recent investment activity
KANDO id: 3058
Corporate information
Official name
Nextech Invest Ltd
Also known as
Nextech Venture
Registration country
Funds managed
| Fund | Type | Vintage | Currency | Committed capital |
|---|---|---|---|---|
| Nextech Oncology IV | Venture | 2015 | USD | 64,000,000 |
| Nextech III Oncology LPCI | Venture | 2010 | EUR | 34,000,000 |
| Nextech II Oncology | Venture | 2008 | EUR | 41,000,000 |
| Nextech I Life Science | Venture | 1999 | CHF | 70,000,000 |
Funding rounds
Investment preferences
Investment criteria
Focus on oncology.
Investment activity status
Active investor
Selected investments
Displaying 1 - 5 of 5| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Palyon Medical Corp | N/A | ||||
|
|
Sunesis Pharmaceuticals Inc | Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and he | N/A | |||
|
|
TetraLogic Pharmaceuticals | A leader in the discovery and development of small molecule drugs called Smac mimetics for the treatment of cancers. | Series C (USD 6,000,000) | |||
|
|
Agensys Inc | Series D | ||||
|
|
MacroGenics Inc | Biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases. | N/A |